Last Update

2014-12-23T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Andrew Cohan?

Andrew Cohan

Portfolio Manager

Macoma Capital Group LLC

HQ Phone: (646) 397-1272

Email: a***@***.com

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Macoma Capital Group LLC

349 Broadway

New York, New York 10013

United States

Company Description

Macoma capital is an opportunistic private equity firm that uses a disciplined, nimble approach to investing. Through a rigorous and consistent process that spans asset classes, sectors, and investment types, we identify private investment opportunities w ... more

Find other employees at this company (3)

Background Information

Employment History

Position, Healthcare Investment Banking Group

Merrill Lynch & Co. Inc

Affiliations

Member of the Biotechnology Team In the Equity Research Division
Goldman , Sachs & Co.

Education

Bachelor of Science

Biochemistry

University of Virginia

Web References (4 Total References)


Andrew ...

www.macomacapital.com [cached]

Andrew Cohan

...
Andrew Cohan
Prior to co-founding Macoma in 2010, Andrew worked at Perry Capital, a multi-strategy, multi-billion dollar hedge fund headquartered in New York City. While at Perry, Andrew was a member of a six-person illiquid special situations investment team, where he focused on a variety of private investments across industries.
Prior to working on illiquid investments, Andrew held primary responsibility for investing in healthcare products companies on Perry's long/short equities team including biotechnology, pharmaceuticals, specialty pharmaceuticals, medical technology and equipment. Specifically, he engaged in strategies including long/short equities, merger arbitrage, credit and private equity.
Before joining Perry, Andrew was a member of the biotechnology team in the equity research division at Goldman Sachs. At Goldman, he worked for an Institutional Investor #2 ranked biotechnology team.
Prior to Goldman, Andrew worked in the healthcare investment banking group at Merrill Lynch. He executed over $27 billion of transactions while at Merrill Lynch, including mergers & acquisitions, debt/equity financings, and IPOs.
Andrew earned a Bachelor of Science in Biochemistry from the University of Virginia, where he was an Echols Scholar and graduated Phi Beta Kappa.


Opalesque New Manager Series Archive

www.opalesque.com [cached]

Guest Article: Andrew Cohan of Macoma Capital Group talks about entrepreneurs who are achieving results


Opalesque Other Voices | Hedge Fund Industry News

www.opalesque.com [cached]

This article was authored by Andrew Cohan, founding member and portfolio manager at Macoma Capital Group, an opportunistic direct investing/special opportunities partnership specifically tailored for large family offices. In today's ch


Andrew ...

www.macomacapital.com [cached]

Andrew Cohan

...
Andrew Cohan
Prior to co-founding Macoma in 2010, Andrew worked at Perry Capital, a multi-strategy, multi-billion dollar hedge fund headquartered in New York City. While at Perry, Andrew was a member of a six-person illiquid special situations investment team, where he focused on a variety of private investments across industries.
Prior to working on illiquid investments, Andrew held primary responsibility for investing in healthcare products companies on Perry's long/short equities team including biotechnology, pharmaceuticals, specialty pharmaceuticals, medical technology and equipment. Specifically, he engaged in strategies including long/short equities, merger arbitrage, credit and private equity.
Before joining Perry, Andrew was a member of the biotechnology team in the equity research division at Goldman Sachs. At Goldman, he worked for an Institutional Investor#2 ranked biotechnology team.
Prior to Goldman, Andrew worked in the healthcare investment banking group at Merrill Lynch. He executed over $27 billion of transactions while at Merrill Lynch, including mergers & acquisitions, debt/equity financings, and IPOs.
Andrew earned a Bachelor of Science in Biochemistry from the University of Virginia, where he was an Echols Scholar and graduated Phi Beta Kappa.

Similar Profiles

Other People with this Name

Other people with the name Cohan

Joni Cohan
Texas Freedom Network

Dona Cohan
Anderson Direct Marketing

Jay Cohan
Western Technology Investment

Larkin Cohan
Washington Tennis Education Foundation

Gail Cohan
Syntrio Inc

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory